Spontaneous transformation of an immortalized hepatocyte cell line: Potential role of a nuclear protease

Cancer Letters

Volumn 213, Issue 1, 2004, Pages 39-48

  Drubin, David A ^a   Clawson, Gary A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

amc, 7 amino 4 methyl coumarin; BS, Bloom's syndrome; Carcinogenesis; cmk, chloromethyl ketone; NS, nuclear scaffold; NSPA, nuclear scaffold associated protease activity; Nuclear protease; Nucleus; PI, protease inhibitor; Protease inhibitors; SV40

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BACTERIUM; CELL IMMORTALIZATION; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; ENZYME ACTIVITY; GENOMICS; LIVER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; YEAST;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, NEOPLASTIC; CHYMASES; HEPATOCYTES; LIVER NEOPLASMS; PHENOTYPE; RATS; SERINE ENDOPEPTIDASES;

EID: 4344683483     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.045     Document Type: Article

References (53)

1. Kennedy A.R. Chemopreventive agents: protease inhibitors. Pharmacol. Ther. 78:1998;167-209
2. Troll W., Klassen A., Janoff A. Tumorigenesis in mouse skin: inhibition by synthetic inhibitors of proteases. Science. 169:1970;1211-1213
3. Kennedy A.R., Beazer-Barclay Y., Kinzler K.W., Newberne P.M. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res. 56:1996;679-682
4. Becker F.F. Inhibition of spontaneous hepatocarcinogenesis in C3H/HeN mice by Edi Pro A, an isolated soy protein. Carcinogenesis. 2:1981;1213-1214
5. Kennedy A.R., Radner B.S., Nagasawa H. Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome. Proc. Natl Acad. Sci. USA. 81:1984;1827-1830
6. Kennedy A.R. The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors. Carcinogenesis. 6:1985;1441-1445
7. Habres J.M., Billings P.C. Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors. Cancer Lett. 63:1992;135-142
8. Billings P.C., Habres J.M. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc. Natl Acad. Sci. USA. 89:1992;3120-3124
9. Billings P.C., Habres J.M., Liao D.C., Tuttle S.W. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res. 51:1991;5539-5543
10. Moy L.Y., Billings P.C. A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Cancer Lett. 85:1994;205-210
11. Lippman S.M., Matrisian L.M. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin. Cancer Res. 6:2000;4599-4603
12. Clawson G.A., Norbeck L.L., Hatem C.L., Rhodes C., Amiri P., McKerrow J.H., et al. Ca(2+)-regulated serine protease associated with the nuclear scaffold. Cell Growth Differ. 3:1992;827-838
13. Clawson G.A., Norbeck L.L., Wise J.P., Patierno S.R. An inhibitor of nuclear scaffold protease blocks chemical transformation of fibroblasts. Cell Growth Differ. 4:1993;589-594
14. Tokes Z.A., Clawson G.A. Proteolytic activity associated with the nuclear scaffold. The effect of self-digestion on lamins. J. Biol. Chem. 264:1989;15059-15065
15. Madsen K.R., Fiskum G., Clawson G.A. Regulation of nuclear scaffold protease activity by calcium. Exp. Cell Res. 187:1990;343-345
16. Clawson G.A., Madsen K.R., Blankenship L.J., Hatem C.L. Alterations in nuclear scaffold constituents during carbon tetrachloride-induced liver regeneration. Hepatology. 13:1991;515-522
17. Clawson G.A., Ren L., Isom H.C. Nuclear scaffold-associated protease: in situ nuclear localization and effects of a protease inhibitor on growth and morphology of a ras-transformed hepatocyte cell line. Hepatology. 22:1995;1230-1235
18. Isom H.C., Woodworth C.D., Meng Y., Kreider J., Miller T., Mengel L. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes. Cancer Res. 52:1992;940-948
19. Woodworth C., Secott T., Isom H.C. Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells. Cancer Res. 46:1986;4018-4026
20. Woodworth C.D., Isom H.C. Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium. Mol. Cell Biol. 7:1987;3740-3748
21. Woodworth C.D., Kreider J.W., Mengel L., Miller T., Meng Y.L., Isom H.C. Tumorigenicity of simian virus 40-hepatocyte cell lines: effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes. Mol. Cell Biol. 8:1988;4492-4501
22. Liao W.S., Ma K.T., Woodworth C.D., Mengel L., Isom H.C. Stimulation of the acute-phase response in simian virus 40-hepatocyte cell lines. Mol. Cell Biol. 9:1989;2779-2786
23. Lowry O.H., Rosbrough J.J., Farr A.L., Randall R.J. Protein measurement with the folin reagent. J. Biol. Chem. 193:1951;265-275
24. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649
25. Li R., Yerganian G., Duesberg P., Kraemer A., Willer A., Rausch C., Hehlmann R. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc. Natl Acad. Sci. USA. 94:1997;14506-14511
26. Hakura A., Mochida H., Yamatsu K. Dimethyl sulfoxide (DMSO) is mutagenic for bacterial mutagenicity tester strains. Mutat. Res. 303:1993;127-133
27. Nakamura S., Oda Y., Ugawa M. Induction of umu gene expression in Salmonella typhimurium TA1535/pSK1002 by dimethyl sulfoxide (DMSO). Mutat. Res. 229:1990;11-15
28. Chen W., Hahn W.C. SV40 early region oncoproteins and human cell transformation. Histol. Histopathol. 18:2003;541-550
29. Butel J.S., Tevethia S.S., Nachtigal M. Malignant transformation in vitro by non-oncogenic variants of defective SV40 (PARA). J. Immunol. 106:1971;969-974
30. Tevethia S.S., McMillan V.L. Acquisition of malignant properties by SV40-transformed mouse cells: relationship to type-C viral antigen expression. Intervirology. 3:1974;269-276
31. Takemoto K.K., Ting R.C., Ozer H.L., Fabisch P. Establishment of a cell line from an inbred mouse strain for viral transformation studies: simian virus 40 transformation and tumor production. J. Natl Cancer Inst. 41:1968;1401-1409
32. Kit S., Kurimura T., Dubbs D.R. Transplantable mouse tumor line induced by injection of SV40-transformed mouse kidney cells. Int. J. Cancer. 4:1969;384-392
33. Wesslen T. SV40-tumorigenesis in mouse. Acta Pathol. Microbiol. Scand [B] Microbiol. Immunol. 78:1970;479-487
34. Kennedy A.R., Little J.B. Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature. 276:1978;825-826
35. Kennedy A.R., Little J.B. Effects of protease inhibitors on radiation transformation in vitro. Cancer Res. 41:1981;2103-2108
36. Kennedy A.R., Cairns J., Little J.B. Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature. 307:1984;85-86
37. Wintersberger U. The selective advantage of cancer cells: a consequence of genome mobilization in the course of the induction of DNA repair processes? (Model studies on yeast). Adv. Enzyme Regul. 22:1984;311-323
38. German J. Bloom's syndrome. Dermatol. Clin. 13:1995;7-18
39. Hickson I.D. RecQ helicases: caretakers of the genome. Nat. Rev. Cancer. 3:2003;169-178
40. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis. 1995;ASM Press, Washington, DC
41. d'Ari R. The SOS system. Biochimie. 67:1985;343-347
42. Goodman M.F. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu. Rev. Biochem. 71:2002;17-50
43. Frank E.G., Ennis D.G., Gonzalez M., Levine A.S., Woodgate R. Regulation of SOS mutagenesis by proteolysis. Proc. Natl Acad. Sci. USA. 93:1996;10291-10296
44. Meyn M.S., Rossman T., Troll W. A protease inhibitor blocks SOS functions in Escherichia coli: antipain prevents lambda repressor inactivation, ultraviolet mutagenesis, and filamentous growth. Proc. Natl Acad. Sci. USA. 74:1977;1152-1156
45. Little J.W., Edmiston S.H., Pacelli L.Z., Mount D.W. Cleavage of the Escherichia coli lexA protein by the recA protease. Proc. Natl Acad. Sci. USA. 77:1980;3225-3229
46. Witkin E.M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol. Rev. 40:1976;869-907
47. Rossman T.G., Klein C.B. Mammalian SOS system: a case of misplaced analogies. Cancer Invest. 3:1985;175-187
48. Berezney R. Regulating the mammalian genome: the role of nuclear architecture. Adv. Enzyme Regul. 42:2002;39-52
49. Berezney R., Coffey D.S. Nuclear protein matrix: association with newly synthesized DNA. Science. 189:1975;291-293
50. Berezney R., Mortillaro M.J., Ma H., Wei X., Samarabandu J. The nuclear matrix: a structural milieu for genomic function. Int. Rev. Cytol. 162A:1995;1-65
51. Leonhardt H., Rahn H.P., Weinzierl P., Sporbert A., Cremer T., Zink D., Cardoso M.C. Dynamics of DNA replication factories in living cells. J. Cell Biol. 149:2000;271-280
52. Nickerson J.A., Blencowe B.J., Penman S. The architectural organization of nuclear metabolism. Int. Rev. Cytol. 162A:1995;67-123
53. Suzuki K., Ojima M., Kodama S., Watanabe M. Radiation-induced DNA damage and delayed induced genomic instability. Oncogene. 22:2003;6988-6993